Come at me, comrade.
The Article: Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India by Thomas Bollyky in The Atlantic.
The Text: Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It’s seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.
Last week, India’s highest court rejected an application to patent Gleevec. While the legal issue in the case is important — the patentability of modifications to existing drugs under Indian law — the impact of the decision will likely be broader than just that issue, escalating a long-simmering fight over patented cancer medications in emerging markets.
The Mormon bartender is scared.
Picture the hang-dog faced cast of Napoleon Dynamite. Try to remember the frumpier extras in the back. Now try to imagine the pudgier ones who didn’t make final cut. And you have the scared Mormon bartender.
He doesn’t have the cast’s awkward, goofy charm. He has a mullet, a gift for awkward silences, a name tag that reads Tyler. So he wasn’t in Napoleon Dynamite. He is the scared Mormon bartender at Outback Steakhouse.
Tyler doesn’t know much about alcohol. But he doesn’t have the social grace for reception up front, either. So management sticks him in the back. At the bar. With less lighting and, this being Provo, Utah, with few to no drinking customers.
Except tonight. Tonight I am hosting a senior sales manager from France.
And the Mormon bartender is scared.